Gilead Sciences
News roundup for Gilead Sciences, Inc., a California-based biopharmaceutical company. It’s most known for researching and developing antiviral drugs used to treat HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19.
Latest
STAT Plus: Gilead wins U.S. approval for drug to treat autoimmune liver disease
STAT Plus: A pricey Gilead HIV drug could be made for dramatically less than the company charges, researchers say
STAT Plus: Gilead’s chief medical officer to leave as R&D efforts stall
STAT Plus: Biden administration appeals jury finding in battle over patents for HIV prevention pills
STAT Plus: Gilead’s twice-yearly antiviral protected women from HIV infection in large trial
STAT Plus: Gilead gets a boost from California court in a case over slow-walking an HIV drug
Study: Gilead antiviral drug shows promise as a treatment for Ebola Sudan
All Coverage
advertisement
